Paul Emery, MA, MD, receives prestigious Nachman Prize.
The Forward View in Rheumatology
Future leaders convene at the ACR/Arthritis Foundation Rheumatology Research Workshop to discuss cutting-edge research and career development.
Drug Updates
Information on new approvals and medication safety.
Minerals, Mud, Martinis, and Methylprednisone
How the practice of rheumatology differs in America and Europe.
Tech Talk: Apps Put More Rheumatology Information at Fingertips
With more and more mobile devices and apps coming onto the market, more and more information is available to rheumatologists on the go.
A Rheumatologic Perspective on Intimacy and Chronic Illness
Sexual dysfunction is frequently one of the first manifestations of physical illness, but is often not inquired about on routine reviews of systems.
Désirée Van Der Heijde, MD, PhD, a Key Driver of Treatment Advances
Dr. van der Heijde learned early in her career that serendipity often plays a role in clinical research and treatment advances.
The Three-Fold Cord of Rheumatology
How the proverbial three-fold cord applies to rheumatology.
Treatment Patterns and Trends for Spondylarthropathies
Methotrexate is a commonly used disease-modifying antirheumatic drug (DMARD) for treating patients with psoriatic arthritis (PsA). However, is it truly as effective as many think it is? That’s the question raised during the session “Spondylarthropathies: Recent Insights,” which took place at the 2011 ACR/ARHP Annual Scientific Meeting in November.
Pain is a Tricky Thing to Treat, or Even Evaluate
Rheumatology is such a gratifying and emotionally rewarding medical specialty. There is no better feeling than helping patients with conditions whose proper diagnosis and management have eluded other practitioners. A patient with diffuse idiopathic skeletal hyperostosis (DISH) presents with pain, and a major clinical tenet of DISH has been its lack of association with pain.